Feb 17
C for COVID
C for COVID
VACCINE STATUS
 
INDIA
 
Vaccine trials are under different stages of finalisation. The Government of India (GoI) has given Emergency Use Authorisation (EUA) for COVISHIELD (developed by Oxford/AstraZeneca and manufactured by Serum Institute of India) and presently being administered to frontline health-care workers. COVAXIN (of Bharat BioTech) has also been given EUA and is being administered in a few of centres.
 
The vaccination started on 16 January and more than 33 lakh health-care workers are vaccinated across the country. So far, only 213 Adverse Effects Following Immunisation (AEFI) have been reported but thankfully, there is no death attributed directly to the vaccines.
 
COUNTRY WISE VACCINE DOSES
 
World 94.91 million till Jan 30
United States 31.12 million till Jan 31
China 22.77 million till Jan 27
European Union 12.20 million till Jan 30
United Kingdom 9.47 million till Jan 30
England 8.25 million till Jan 30
Israel 4.74 million till Jan 30
India 3.74 million till Jan 30
United Arab Emirates 3.33 million till Jan 31
Germany 2.32 million till Jan 29
Brazil 2.07 million till Jan 31
Turkey 1.99 million till Jan 31
Italy 1.96 million till Jan 31
France 1.53 million till Jan 30
Spain 1.47 million till Jan 28
Poland 1.16 million till Jan 30
Russia 1.00 million till Jan 13
Canada 937,338 till Jan 29
 
SITUATION UPDATE
 
GLOBAL
 
Globally a total of 103,534,039 cases have been reported till 31 Jan 2021. Of this, 75,136, 791 (97%) have recovered and 2,237,880 (3%) deaths have been reported.
 
INDIA
 
The daily new cases are declining. With a recovery rate of 97%, India’s cumulative recoveries continue to be highest till the world.
 
31 January #COVID19 Snapshot
• Confirmed cases:  1,07,58,619
• Recovered:   1,04,33,988 (96.98%)
• Active cases:   1,65,704 (1.54%)
• Deaths:   1,54,428 (1.44%)

Comments

There are no comments for this post.